Latest Regulatory News

IRIS Metals has raised $4.267 million through a share placement to fund lithium exploration and development in South Dakota, aiming for a feasibility study completion by early 2026.

Osteopore Limited has posted a record AUD 835K revenue in Q2 CY25, driven by strong APAC sales and new European market access following EU MDR clearance. The company also advances clinical trials and refreshes key distribution channels.

CZR Resources has secured shareholder and regulatory approval to sell its Robe Mesa iron ore project for A$75 million, positioning the company to focus on promising gold and base metal exploration in Western Australia.

Equatorial Resources Limited reports progress in its ICSID arbitration against the Republic of Congo and faces uncertainty over exploration permits in Guinea, while maintaining a solid cash position.

American Rare Earths Limited reports strong progress at its Halleck Creek Rare Earths Project, highlighted by exceptional sampling results, key permitting milestones, and a $15 million equity raise to fund development.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.

Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.

Energy Resources of Australia Ltd narrowed its half-year loss to $35 million as it pressed ahead with the complex rehabilitation of the Ranger Project Area, backed by $1.24 billion in cash and investments. Meanwhile, Rio Tinto moves to compulsorily acquire remaining shares, signaling a new chapter for ERA’s future.

Po Valley Energy reports steady gas production from its Podere Maiar-1 field and progresses permitting for new wells in Italy, supported by robust cash reserves and ongoing stakeholder engagement.

Astron Corporation has cleared major regulatory hurdles for its Donald Rare Earth and Mineral Sands Project, releasing a robust updated economic study that underscores the project's long-term value and advancing financing discussions.

Acrux Limited has secured a decade-long licensing agreement with Servacure to commercialise its FDA-approved Dapsone 5% Gel in Saudi Arabia, marking a strategic step in its global expansion.

Helios Energy has made significant strides in transitioning from exploration to production at its Presidio Project in Texas, supported by a $2.6 million capital raise and strategic U.S. hires. Early oil recovery and positive engagement with partners underscore its growing momentum.